发明名称 |
Therapeutic Compositions Comprising Imidazole and Imidazolium Compounds |
摘要 |
Therapeutic compositions comprising substituted imidazole or imidazolium compounds may be used for a number of medical purposes, such as treatment of undesirable conditions or diseases, including disease or conditions related to bone, cancer, and/or pain. |
申请公布号 |
US2016095872(A1) |
申请公布日期 |
2016.04.07 |
申请号 |
US201514968514 |
申请日期 |
2015.12.14 |
申请人 |
Antecip Bioventures II LLC |
发明人 |
Tabuteau Herriot |
分类号 |
A61K31/675;A61K9/20;A61K9/48;A61K9/00 |
主分类号 |
A61K31/675 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating knee pain comprising orally administering a dosage form to a mammal in need thereof, wherein the dosage form comprises: in an amount that is less than 0.1% w/w, and greater than 0% w/w; or in an amount that is less than 0.1% w/w, and greater than 0% w/w; wherein any amount in % w/w is based upon the total weight of Compound A, Compound B, and Compound C; wherein each A is independently an acidic functional group; wherein the bioavailability of zoledronic acid in the dosage form is from about 1.1% to about 4%. |
地址 |
New York NY US |